Abalone Bio YC 지원서

Winter 2020Active

Abalone Bio은(는) Winter 2020 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Winter 2020
산업: HealthcareDrug Discovery and Delivery
팀 규모: 14
상태: Active
출시됨: 2020

창업자

Richard YuFounder
Gustavo PesceFounder

Abalone Bio의 사업 내용

Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year. + High throughput experimental measurement uniquely leverages AI/ML: We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs) + Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech. + Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value. + Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.

Abalone Bio의 YC 지원서, 재구성됨

Y Combinator 지원

Abalone Bio, Winter 2020 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Abalone Bio

Describe what your company does in 50 characters or less.

We create activating antibodies to treat diseases others can't.

What is your company going to make? Please describe your product and what it does or will do.

We build a platform that combines high-throughput experimental antibody screening with machine learning to discover activating antibodies targeting cell-specific receptors. Our product enables discovery and optimization of rare antibody hits against challenging targets like GPCRs, starting in obesity and metabolic diseases, focusing on safety and efficacy beyond current drugs.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and the company is based here.

Explain your decision regarding location.

San Francisco is a hub for biotech and AI talent, which is critical for our platform combining synthetic biology and machine learning. Being in SF keeps us close to partners and investors focused on healthcare innovation.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

Abalone Bio의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Abalone Bio의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Abalone Bio과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.